Hesse Marlen, Arenz Christoph
Institute for Chemistry, Humboldt Universität zu Berlin, Berlin, Germany.
Methods Mol Biol. 2014;1095:11-25. doi: 10.1007/978-1-62703-703-7_2.
Numerous studies describe alterations in the levels of specific microRNAs (miRNAs) that are associated with human pathologies. Some of these alterations may give rise to the development of novel diagnostic tools, while certain miRNAs additionally could serve as novel drug targets. Moreover, components of the miRNA maturation machinery may be up- or down-regulated in human disease. In such cases, the consequences for the expression of individual miRNAs are however only poorly understood. Herein, we review the current knowledge of how miRNAs are linked to human disease and which parts of the miRNA maturation machinery could serve as future drug targets.
众多研究描述了与人类疾病相关的特定微小RNA(miRNA)水平的变化。其中一些变化可能会催生新的诊断工具,而某些miRNA还可作为新的药物靶点。此外,miRNA成熟机制的组成部分在人类疾病中可能会上调或下调。然而,在这种情况下,对于单个miRNA表达的影响却知之甚少。在此,我们综述了目前关于miRNA如何与人类疾病相关联以及miRNA成熟机制的哪些部分可作为未来药物靶点的知识。